Home/Filings/4/0001628280-24-046462
4//SEC Filing

de Verneuil Vanina 4

Accession 0001628280-24-046462

CIK 0001706431other

Filed

Nov 6, 7:00 PM ET

Accepted

Nov 7, 7:20 PM ET

Size

4.8 KB

Accession

0001628280-24-046462

Insider Transaction Report

Form 4
Period: 2024-11-06
de Verneuil Vanina
EVP and General Counsel
Transactions
  • Sale

    Common Stock

    2024-11-06$10.11/sh4,397$44,45456,973 total
Footnotes (1)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 5, 2024.

Issuer

Vir Biotechnology, Inc.

CIK 0001706431

Entity typeother

Related Parties

1
  • filerCIK 0002036234

Filing Metadata

Form type
4
Filed
Nov 6, 7:00 PM ET
Accepted
Nov 7, 7:20 PM ET
Size
4.8 KB